BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7159752)

  • 1. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
    Berkowitz LR; Orringer EP
    J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cetiedil on red cell membrane permeability.
    Schmidt WF; Asakura T; Schwartz E
    Blood Cells; 1982; 8(2):289-98. PubMed ID: 7159753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of sickling.
    Mentzer WC
    Am J Pediatr Hematol Oncol; 1982; 4(3):320-7. PubMed ID: 7149171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the mechanism by which cetiedil inhibits sickling.
    Abu-Salah KM; Gambo AH
    Life Sci; 2002 Jan; 70(9):1003-11. PubMed ID: 11860149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetiedil-induced increase in water exchange in sickle cell anemia erythrocytes.
    Narasimhan C; Fung LW
    J Pharm Sci; 1991 Nov; 80(11):1101-2. PubMed ID: 1815064
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of cetiedil on cation and water movements in erythrocytes.
    Schmidt WF; Asakura T; Schwartz E
    J Clin Invest; 1982 Mar; 69(3):589-94. PubMed ID: 7061704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of erythrocyte calcium transport by cetiedil.
    Levine SN; Berkowitz LR; Orringer EP
    Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell membrane abnormalities in sickle cell anemia.
    Bookchin RM; Lew VL
    Prog Hematol; 1983; 13():1-23. PubMed ID: 6322226
    [No Abstract]   [Full Text] [Related]  

  • 14. New antisickling agents.
    Labie D
    Haematologia (Budap); 1983; 16(1-4):105-8. PubMed ID: 6679483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of abnormal hemoglobins on the membrane regulation of cell hydration.
    Clark MR; Shohet SB
    Tex Rep Biol Med; 1980-1981; 40():417-29. PubMed ID: 7034277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of sickle cell anemia with induced hyponatremia.
    Rosa RM; Bierer BE; Bunn HF; Epstein FH
    Blood Cells; 1982; 8(2):329-35. PubMed ID: 7159756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H; Yatco E; Benjamin LJ; Manning JM
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of the rate of erythrocyte sickling by RMI 11,071A and its possible mechanism.
    MacKenzie RD; Gleason EM; Schatzman GL; Cawein MJ
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):224-6. PubMed ID: 504233
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.